CAL 27 is an oral adenosquamous carcinoma cell line

被引：42

作者：

Jiang, Lu ^{[1
]}

Ji, Ning ^{[1
,2
]}

Zhou, Yu ^{[1
]}

Li, Jing ^{[1
,2
]}

Liu, Xianting ^{[1
,2
]}

Wang, Zhi ^{[1
]}

Chen, Qianming ^{[1
]}

Zeng, Xin ^{[1
]}

机构：

[1] Sichuan Univ, W China Coll Stomatol, State Key Lab Oral Dis, Chengdu 610041, Sichuan, Peoples R China

[2] Sichuan Univ, Minist Educ, Key Lab Bioresources & Ecoenvironm, Chengdu 610041, Sichuan, Peoples R China

来源：

ORAL ONCOLOGY | 2009年 / 45卷 / 11期

基金：

中国国家自然科学基金;

关键词：

CAL; 27; Adenosquamous carcinoma; Cell line; HUMAN HEAD; IN-VITRO; GROWTH; CANCER; VIVO; RECEPTOR;

D O I：

10.1016/j.oraloncology.2009.06.001

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

CAL 27 is one of the most frequently used cell lines in the field of oral squamous cell carcinoma ( OSCC) studying. However, our recent studies showed that the growth pattern of CAL 27 xenograft did not seem like typical OSCC. In this study, we verified the identity of CAL 27 cells by using by short tandem repeat analysis. Then, we performed tumor formation assay, HE staining and immunohistochemistry assay to further study the growing characteristics and histopathological diagnosis of CAL 27 xenografts. Our results showed that CAL 27 xenografts grew slowly in vivo with vesicle formation at both the surfaces and deeper areas of the tumors. The CAL 27 xenografts were then diagnosed as oral adenosquamous carcinomas. Thus CAL 27 appears to be an oral adenosquamous carcinoma cell line. (C) 2009 Elsevier Ltd. All rights reserved.

引用

页码：E204 / E207

页数：4

共 19 条

[1]

In vitro and in vivo effects of repifermin (keratinocyte growth factor-2, KGF-2) on human carcinoma cells [J].

Alderson, R ;

Gohari-Fritsch, S ;

Olsen, H ;

Roschke, V ;

Vance, C ;

Connolly, K .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2002, 50 (03) :202-212

[2]

Profiling and authentication of human cell lines using short tandem repeat (STR) loci: Report from the National Cell Bank of Iran [J].

Azari, Shahram ;

Ahmadi, Nahid ;

Tehrani, Mahmood Jeddi ;

Shokri, Fazel .

BIOLOGICALS, 2007, 35 (03) :195-202

[3]

Azemar M, 2000, INT J CANCER, V86, P269, DOI 10.1002/(SICI)1097-0215(20000415)86:2<269::AID-IJC18>3.0.CO

[4]

2-8

[5]

Aznavoorian S, 2001, CANCER RES, V61, P6264

[6]

Bosnar MH, 2008, NEOPLASMA, V55, P447

[7]

2 NEW HUMAN-TUMOR CELL-LINES DERIVED FROM SQUAMOUS-CELL CARCINOMAS OF THE TONGUE - ESTABLISHMENT, CHARACTERIZATION AND RESPONSE TO CYTO-TOXIC TREATMENT [J].

GIOANNI, J ;

FISCHEL, JL ;

LAMBERT, JC ;

DEMARD, F ;

MAZEAU, C ;

ZANGHELLINI, E ;

ETTORE, F ;

FORMENTO, P ;

CHAUVEL, P ;

LALANNE, CM ;

COURDI, A .

EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1988, 24 (09) :1445-1455

[8]

Oral cancer overexpressed 1 (ORAOV1): A regulator for the cell growth and tumor angiogenesis in oral squamous cell carcinoma [J].

Jiang, Lu ;

Zeng, Xin ;

Yang, Hanshuo ;

Wang, Zhi ;

Shen, Jun ;

Bai, Jingping ;

Zhang, Yuanyuan ;

Gao, Feng ;

Zhou, Min ;

Chen, Qianming .

INTERNATIONAL JOURNAL OF CANCER, 2008, 123 (08) :1779-1786

[9]

Lupeol suppresses cisplatin-induced nuclear factor-κB activation in head and neck squamous cell carcinoma and inhibits local invasion and nodal metastasis in an orthotopic nude mouse model [J].

Lee, Terence K. ;

Poon, Ronnie T. P. ;

Wo, Jana Y. ;

Ma, Stephanie ;

Guan, Xin-Yuan ;

Myers, Jeffrey N. ;

Altevogt, Peter ;

Yuen, Anthony P. W. .

CANCER RESEARCH, 2007, 67 (18) :8800-8809

[10]

p120cat delocalization in cell lines of oral cancer [J].

Lo Muzio, L ;

Pannone, G ;

Staibano, S ;

Mignogna, MD ;

Serpico, R ;

Fanali, S ;

De Rosa, G ;

Piattelli, A ;

Mariggio, MA .

ORAL ONCOLOGY, 2002, 38 (01) :64-72

← 1 2 →